In this Issue:
Metformin and energy intake/satiety in obese children
U300 glargine in type 2 diabetes
Short-term LY2409021 lowers blood glucose
Decision support tool for appropriate glucose-lowering therapy in type 2 diabetes
Glucose, insulin and insulin resistance, and memory performance
Preventing diabetes with benefit-based tailored treatment
Lowering BP in type 2 diabetes
HMG-CoA reductase inhibition, type 2 diabetes and bodyweight
6 vs. 12 weeks of antibiotics for diabetic foot osteomyelitis
104 weeks of canagliflozin for type 2 diabetes
Please login below to download this issue (PDF)